Pharmacokinetics and Safety of High-Dose and Extended-Interval Regimens of Levofloxacin in Human Immunodeficiency Virus-Infected Patients

The pharmacokinetics of levofloxacin, administered in high doses and with extended dosing intervals, was studied in human immunodeficiency virus (HIV)-infected patients. Thirty patients received either 750 mg of the drug or a placebo once daily for 14 days, followed by 750 mg or 1,000 mg of the drug...

Descripción completa

Detalles Bibliográficos

Publicado en:	Antimicrob Agents Chemother
Autores principales:	Piscitelli, Stephen C., Spooner, Katherine, Baird, Barbara, Chow, Andrew T., Fowler, Cynthia L., Williams, Rex R., Natarajan, Jaya, Masur, Henry, Walker, Robert E.
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	American Society for Microbiology (ASM) 1999
Materias:	Pharmacology
Acceso en línea:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89473/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10471591/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.43.9.2323
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!